France to back Roche cancer drug as cheaper eye treatment

July 2, 2014 9:51 AM

5 0

France to back Roche cancer drug as cheaper eye treatment

PARIS (Reuters) - The French government, looking to cut healthcare costs, plans to authorize the use of Roche cancer drug Avastin as an alternative eye disease treatment to the much pricier Lucentis, marketed by both Roche and Novartis.

The government said on Monday it had introduced an amendment to its social security budget bill that would allow doctors to use Avastin as a treatment for age-related macular degeneration (AMD)- a leading cause of blindness among the elderly.

Also read: REFILE-UPDATE 1-Baker Hughes to form fracturing JV with Goldman Sachs, CSL Capital

Read more

To category page

Loading...